Evidence map›Paper›PMID 35880159›Full record

ArticleFrontiers in oncology2022

The Value of CT-Based Radiomics for Predicting Spread Through Air Spaces in Stage IA Lung Adenocarcinoma.

Xiaoyu Han, Jun Fan, Yuting Zheng, Chengyu Ding, Xiaohui Zhang, Kailu Zhang, Na Wang, Xi Jia, Yumin Li, Jia Liu and 2 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. CT feature-based nomogram for predicting tumor spread through air spaces in stage IA lung adenocarcinoma.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaoyu HanDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jun FanDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuting ZhengDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chengyu DingClinical Solution, Philips Healthcare, Shanghai, China.
Xiaohui ZhangClinical Solution, Philips Healthcare, Shanghai, China.
Kailu ZhangDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Na WangDepartment of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xi JiaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yumin LiDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jia LiuDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Jinlong ZhengDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Heshui ShiDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Spread through air spaces (STAS), a new invasive pattern in lung adenocarcinoma (LUAD), is a risk factor for poor outcome in early-stage LUAD. This study aimed to develop and validate a CT-based radiomics model for predicting STAS in stage IA LUAD. Methods: A total of 395 patients (169 STAS positive and 226 STAS negative cases, including 316 and 79 patients in the training and test sets, respectively) with stage IA LUAD before surgery were retrospectively included. On all CT images, tumor size, types of nodules (solid, mix ground-glass opacities [mGGO] and pure GGO [pGGO]), and GGO percentage were recorded. Region of interest (ROI) segmentation was performed semi-automatically, and 1,037 radiomics features were extracted from every segmented lesion. Intraclass correlation coefficients (ICCs), Pearson's correlation analysis and least absolute shrinkage and selection operator (LASSO) penalized logistic regression were used to filter unstable (ICC < 0.75) and redundant features (r > 0.8). A temporary model was established by multivariable logistic regression (LR) analysis based on selected radiomics features. Then, seven radiomics features contributing the most were selected for establishing the radiomics model. We then built two predictive models (clinical-CT model and MixModel) based on clinical and CT features only, and the combination of clinical-CT and Rad-score, respectively. The performances of these three models were assessed. Results: The radiomics model achieved good performance with an area under of curve (AUC) of 0.812 in the training set, versus 0.850 in the test set. Furthermore, compared with the clinical-CT model, both radiomics model and MixModel showed higher AUC and better net benefit to patients in the training and test cohorts. Conclusion: The CT-based radiomics model showed satisfying diagnostic performance in early-stage LUAD for preoperatively predicting STAS, with superiority over the clinical-CT model.

Indexed as

adenocarcinomalung cancerradiomicsspread through air spacesstage IA

Identifiers

PMID35880159
PMCPMC9307661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.